Skip to main content
MyPeptideMatch
Reviewed by MyPeptideMatch Editorial TeamLast reviewed October 2026Updated October 2026

Livagen Dosing Protocol: 20 mg Vial, Reconstitution & Units

Livagen (Lys-Glu-Asp-Ala tetrapeptide) liver bioregulator: community-reported dosing, reconstitution math, and what the research does and doesn't support.

Quickstart highlights

Livagen is the synthetic tetrapeptide Lys-Glu-Asp-Ala (KEDA), developed by Vladimir Khavinson's group in St.

  • No human dose has been established. Every amount on this page is community-reported, not from a trial.
  • Amounts quoted online range from about 100 µg to 20 mg a day; 200 µg once daily for 10 days is commonly discussed.
  • 20 mg vial + 10 mL bac water = 2 mg/mL, so 200 µg = 0.1 mL = 10 units.
  • One 20 mg vial holds 100 doses of 200 µg, but if you follow the 28-day use window most of a vial is left after one 10-day course.
  • The research behind Livagen is cell, tissue-culture and rat work. See the Livagen peptide page for the evidence.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

WeekDose (µg)UnitsFrequencyNotes
1-2 (10-day course)20010Once dailyCommunity-reported, not from a trial; 200 µg = 10 units at 2 mg/mL; one 20 mg vial holds 100 doses
Maintenance20010Every other dayCommunity-reported, not from a trial; no study has tested a maintenance schedule

Your free Livagen tracker

  • Dose reminders
  • Injection logging
  • Cycle progress
Create free account Already have one? Sign in

Reconstitution steps

  1. Add 10 mL bacteriostatic water in total to the 20 mg vial, running it slowly down the vial wall. Check first that your vial can hold 10 mL.
  2. Swirl gently until dissolved; do not shake.
  3. Final concentration: 2 mg/mL. On a U-100 insulin syringe, 200 µg = 0.1 mL = 10 units.
  4. Label with the date; refrigerate at 2–8 °C and use within 28 days.

Supplies needed

10_day-week plan

  • 1 vial
  • 10 syringes
  • 10 mL bac water
  • 10 alcohol swabs
Need clinics? See vetted providers →

Protocol overview & cycle notes

Reference schedule and reconstitution math for a 20 mg Livagen vial. Livagen has cell, tissue-culture and rat research but no human trials, so every dose on this page is community-reported, not clinically established.

Off-cycle: Not established. Community sources describe 4–6 months between courses; no study has tested cycle length.

Storage & handling

Lyophilized: store below 25 °C, away from light. Reconstituted: refrigerate at 2–8 °C and use within 28 days.

Injection & tracking tips

  • Community protocols describe subcutaneous injection into abdominal or thigh fat; no study has compared routes or timing.
  • Rotate injection sites and use a new sterile syringe every time.
  • No study has tested Livagen combined with any other peptide or supplement, so combination protocols are untested.
  • Livagen has no human safety data. If you have a liver condition or take medicines processed by the liver, keep your physician involved.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

  • If your physician orders liver tests (ALT, AST, GGT, bilirubin), note the dates relative to each course.
  • Log alcohol use and any medication changes during and after each course.
  • Record any injection-site reactions or other symptoms, with dates.
Log your cycle in the calculator →

How this works & references

Livagen is the synthetic tetrapeptide Lys-Glu-Asp-Ala (KEDA), developed by Vladimir Khavinson's group in St. Petersburg as a liver "bioregulator." In cultured rat hepatocytes it increased protein synthesis, most strongly in cells from old animals, and in lymphocytes from elderly donors it loosened condensed chromatin in the dish. A rat feeding study found small-intestine enzymes barely break it down. There are no published human trials, and most of the research comes from Khavinson's network without independent replication.

Frequently asked questions

What is the Livagen peptide dosage?
There is no established Livagen dosage, because no human trial has tested one. Community-reported amounts for the injectable 20 mg vial range from about 100 µg to 20 mg a day, usually in 10–30 day courses. The schedule on this page, 200 µg once daily for 10 days, is commonly discussed but unverified.
Why do Livagen doses vary so much online?
Because nobody has done dose-finding research. The only Livagen animal study indexed in PubMed is a two-week rat feeding study, and its abstract does not give a dose. The roughly 200-fold spread between quoted amounts reflects that.
What is Livagen used for?
It is marketed for liver health, immune support and anti-aging. The research is cell and tissue-culture work on rat liver cells, one rat study on digestive enzymes, and lab studies on white blood cells from elderly donors. No study has tested it for fatty liver, hepatitis or any other condition in people.
What are the benefits of Livagen?
In lab studies it increased protein synthesis in rat liver cells and loosened tightly packed chromatin in white blood cells from elderly donors. A 2020 review by the developers reports liver-protective effects in animal models. None of these effects has been shown in people taking Livagen.
Is Livagen FDA approved?
No. Livagen has no FDA approval for any use and does not appear in Drugs@FDA or DailyMed. Vials are sold labeled for research use only.

Related protocols

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.